Association between alpha1 antitrypsin (AAT) circulating polymers (CP) and lung and liver disease in patients with AAT deficiency (AATD). Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases Year: 2021
Intra-epithelial polymerization, accumulation and secretion of alpha1 antitrypsin (AAT) Z polymers in the lung of patients with alpha-1 antitrypsin deficiency (AATD) Source: Annual Congress 2010 - Epithelial cell biology Year: 2010
Effect of recombinant α-1 antitrypsin (rAAT) and TAPI on neutrophil elastase (NE) and matrix metalloproteinase-9 (MMP9) activity in induced sputum (IS) from healthy smokers and patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2003 - Progress on therapy for chronic obstructive pulmonary disease Year: 2003
Levels of alkaline phosphatase (ALP), albumin (ALB) and D dimer (DD) in bronchoalveolar lavage (BAL) in patients with Interstitial lung disease (ILD) Source: Eur Respir J 2002; 20: Suppl. 38, 468s Year: 2002
Effects of double dose alpha 1 antitrypsin (AAT) therapy on cytokine pathways in AAT Deficiency (AATD) Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018
A high purity alpha-1 antitrypsin (AAT) from human plasma, TAL6004 Source: Annual Congress 2009 - Treatment of airways disease Year: 2009
Aα360: A measure of disease and treatment efficacy in alpha-1-antitrypsin (A1AT) deficiency Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010
Relationship between levels of serum adenosin deaminase (ADA) and sputum smear conversion in patients with pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 425s Year: 2004
Serum TNFα, CD14 and CRP levels in COPD patients with different alpha-1 antitrypsin phenotypes Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008
Alpha-1 antitrypsin (AAT) polymerization in alveolar macrophages of AAT deficient individuals and in smokers. Source: International Congress 2017 – New Mechanistic Findings in COPD Year: 2017
A phase 1B/2A study to evaluate the effect of aerosolized, recombinant alpha 1-antitrypsin (rAAT) on epithelial lining fluid (ELF) analytes in subjects with AAT deficiency Source: Eur Respir J 2005; 26: Suppl. 49, 287s Year: 2005
Proteinase 3 activity is present in sputum from subjects with alpha-1-antitrypsin deficiency (AATD) and COPD Source: Annual Congress 2012 - The smoking gun in COPD biology Year: 2012
Pulmonary tuberculosis (PT) in patients taking the TNF-a inhibitor inflixinab (INF) Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts Year: 2011
Serum IFN-γ and TNF-α levels in pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 456s Year: 2005
Regional deposition of 99m Tc-labelled alpha-1 antitrypsin (AAT) in patients with alpha-1 antitrypsin deficiency and cystic fibrosis (CF) compared with healthy volunteers Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects Year: 2007
Liver function in patients with pulmonary tuberculosis (PT) before and during the initial phase of antituberculosis treatment (ATT) Source: Eur Respir J 2002; 20: Suppl. 38, 365s Year: 2002
Investigating change in the COPD assessment test (CAT) within α-1 antitrypsin deficiency (A1ATD) Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases Year: 2011
High serum CA-125 level in active pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 415s Year: 2005
Early stage asymptomatic (HRCT detectable) patients with IPF showed augmented serum surfactant protein D (SP-D) Source: Eur Respir J 2002; 20: Suppl. 38, 61s Year: 2002
Study of angiotensin-converting enzyme, serum amyloid A, soluble interleukin-2 receptor, lysozyme and KL-6 in serum as diagnostic markers in pulmonary sarcoidosis Source: Annual Congress 2007 - Sarcoidosis: various aspects Year: 2007